Acorda CEO: Filed for approval of Diazepam nasal spray

Now watching

Next video starts in : 7 Play

Acorda CEO: Filed for approval of Diazepam nasal spray

Acorda CEO: Filed for approval of Diazepam nasal spray
Replay video
Up next

Cramer: This high school class should be mandatory

Unlock your personal NFL Now stream by signing in to NFL.com

Acorda CEO: Filed for approval of Diazepam nasal spray

by CNBC Videos 7:04 mins

Acorda Therapeutics president & CEO Dr. Ron Cohen discusses its pipeline and current research, whether epilepsy is an epidemic and its plan for its Diazepam nasal spray.

View Comments (0)